What is GCAND's earnings per share (EPS)?

GCAND (GCAND) reported diluted earnings per share of $0.00 for fiscal year 2024. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

GCAND Financials

GCAND

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

This page shows GCAND (GCAND) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Weak

2/9

GCAND passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass.

Earnings Quality Low Quality

0.61x

For every $1 of reported earnings, GCAND generates $0.61 in operating cash flow (-$109K OCF vs -$179K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

-$179K

YoY+5.0%

GCAND reported -$179K in net income in fiscal year 2024. This represents an increase of 5.0% from the prior year.

EPS (Diluted)

$0.00

GCAND earned $0.00 per diluted share (EPS) in fiscal year 2024.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$57K

YoY-65.6%

5Y CAGR+18.4%

GCAND held $57K in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

536,622

GCAND had 536,622 shares outstanding in fiscal year 2024. This represents a decrease of 99.9% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

GCAND Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	N/A	N/A	N/A	$13K-73.7%	$48K+574.8%	$7K
Cost of Revenue	N/A	N/A	N/A	$13K-73.7%	$48K+1438.9%	$3K
Gross Profit	N/A	N/A	N/A	-$25+45.7%	-$46-101.2%	$4K
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	-$156K+10.9%	-$175K+0.9%	-$177K+48.4%	-$343K-16.5%	-$294K+43.9%	-$525K
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$179K+5.0%	-$188K+47.7%	-$360K+40.2%	-$602K+36.7%	-$951K+42.3%	-$1.6M
EPS (Diluted)	$0.00	$0.00	$0.00	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	-$37K+22.5%	-$48K-10.8%	-$44K	N/A	-$40K-3.0%	-$39K-0.8%	-$39K	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$36K+90.8%	-$391K-61.2%	-$242K	N/A	-$46K-2.8%	-$45K-0.7%	-$45K	N/A
EPS (Diluted)	$-0.04	$0.00	$0.00	N/A	$-0.09	$0.00	$0.00	N/A

GCAND Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$58K-66.5%	$172K-38.6%	$280K-28.6%	$393K+118.2%	$180K+242.0%	$53K
Current Assets	$57K-65.6%	$167K-38.2%	$270K-28.5%	$378K+136.4%	$160K+203.3%	$53K
Cash & Equivalents	$57K-65.6%	$167K-38.2%	$270K-28.5%	$378K+234.2%	$113K+358.0%	$25K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$898K+7.7%	$834K+1.0%	$825K-4.3%	$862K+87.4%	$460K-71.2%	$1.6M
Current Liabilities	$898K+7.7%	$834K+1.0%	$825K-4.3%	$862K+87.4%	$460K-71.2%	$1.6M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$840K-27.1%	-$661K-21.4%	-$545K-16.2%	-$469K-67.6%	-$280K+81.9%	-$1.5M
Retained Earnings	-$4.7M-4.0%	-$4.5M-4.4%	-$4.3M-9.2%	-$3.9M-18.1%	-$3.3M-40.0%	-$2.4M

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Total Assets	$21K-20.1%	$27K-42.2%	$46K-20.0%	$58K-9.6%	$64K-23.2%	$83K-37.6%	$133K-22.5%	$172K
Current Assets	$21K-20.1%	$27K-42.2%	$46K-19.4%	$57K-7.9%	$62K-22.5%	$80K-37.9%	$129K-22.5%	$167K
Cash & Equivalents	$21K-20.1%	$27K-42.2%	$46K-19.4%	$57K-7.9%	$62K-22.5%	$80K-37.9%	$129K-22.5%	$167K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$1.1M+2.8%	$1.1M+8.9%	$1.0M+12.4%	$898K+4.3%	$861K+3.2%	$834K-0.6%	$839K+0.7%	$834K
Current Liabilities	$1.1M+2.8%	$1.1M+8.9%	$1.0M+12.4%	$898K+4.3%	$861K+3.2%	$834K-0.6%	$839K+0.7%	$834K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$1.1M-3.4%	-$1.1M-11.4%	-$963K-14.6%	-$840K-5.4%	-$797K-6.1%	-$751K-6.4%	-$706K-6.7%	-$661K
Retained Earnings	-$5.3M-0.7%	-$5.3M-8.0%	-$4.9M-5.2%	-$4.7M-0.9%	-$4.6M-1.0%	-$4.6M-1.0%	-$4.5M-1.0%	-$4.5M

GCAND Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	-$109K-6.1%	-$103K+4.0%	-$107K+54.3%	-$235K+18.7%	-$290K-1.5%	-$285K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	-$62K	N/A
Financing Cash Flow	N/A	N/A	N/A	$500K+13.7%	$440K+75.9%	$250K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Operating Cash Flow	-$5K+72.5%	-$20K-74.8%	-$11K-127.0%	-$5K+72.8%	-$18K+63.2%	-$49K-30.6%	-$38K-14.9%	-$33K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

GCAND Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	N/A	N/A	N/A	-0.2%-0.1pp	-0.1%-56.2pp	56.1%
Operating Margin	N/A	N/A	N/A	-2716.9%-2104.0pp	-612.9%+6765.2pp	-7378.1%
Net Margin	N/A	N/A	N/A	-4768.2%-2788.4pp	-1979.8%+21174.6pp	-23154.4%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-309.8%-200.5pp	-109.4%+19.1pp	-128.5%+24.8pp	-153.3%+374.8pp	-528.1%+2602.4pp	-3130.5%
Current Ratio	0.06-0.1	0.20-0.1	0.33-0.1	0.44+0.1	0.35+0.3	0.03
Debt-to-Equity	-1.07+0.2	-1.26+0.3	-1.51+0.3	-1.84-0.2	-1.64-0.6	-1.03
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-169.0%+1294.2pp	-1463.2%-938.6pp	-524.6%	N/A	-72.2%-18.2pp	-54.0%-20.5pp	-33.4%	N/A
Current Ratio	0.020.0	0.02-0.0	0.05-0.0	0.060.0	0.07-0.0	0.10-0.1	0.15-0.0	0.20
Debt-to-Equity	-1.020.0	-1.02+0.0	-1.05+0.0	-1.07+0.0	-1.08+0.0	-1.11+0.1	-1.19+0.1	-1.26
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$840K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.06), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

Is GCAND profitable?

No, GCAND (GCAND) reported a net income of -$179K in fiscal year 2024.

What is GCAND's operating cash flow?

GCAND (GCAND) generated -$109K in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are GCAND's total assets?

GCAND (GCAND) had $58K in total assets as of fiscal year 2024, including both current and long-term assets.

How many shares does GCAND have outstanding?

GCAND (GCAND) had 536,622 shares outstanding as of fiscal year 2024.

What is GCAND's current ratio?

GCAND (GCAND) had a current ratio of 0.06 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.

What is GCAND's debt-to-equity ratio?

GCAND (GCAND) had a debt-to-equity ratio of -1.07 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is GCAND's return on assets (ROA)?

GCAND (GCAND) had a return on assets of -309.8% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is GCAND's cash runway?

Based on fiscal year 2024 data, GCAND (GCAND) had $57K in cash against an annual operating cash burn of $109K. This gives an estimated cash runway of approximately 6 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is GCAND's debt-to-equity ratio negative or unusual?

GCAND (GCAND) has negative shareholder equity of -$840K as of fiscal year 2024, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is GCAND's Piotroski F-Score?

GCAND (GCAND) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are GCAND's earnings high quality?

GCAND (GCAND) has an earnings quality ratio of 0.61x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.